BioSpace News Archive

Veeva Systems (NYSE: VEEV) today announced that Merck KGaA, Darmstadt, Germany is using Veeva Vault MedInquiry as its global medical information management system.

AmplifyBio today announced the successful acquisition of a cutting-edge intellectual property (IP) that, among other capabilities, will allow them to offer non-viral gene-editing services to clients.

Novartis and the Novartis US Foundation proudly announce the significant expansion of Beacon of Hope, our 10-year commitment to co-create programs that address health and education inequities and create greater diversity, equity, inclusion and trust across the research and development ecosystem.

Medical device and technology company Lazurite today announced that James Voos, M.D. has joined the company’s medical advisory board.

Akoya Biosciences, Inc. today announced that it will release financial results for the second quarter of 2023 after the market close on Monday, August 7th , 2023.

LianBio today announced a clinical supply agreement with AstraZeneca in China to evaluate the safety and efficacy of BBP-398, an investigational SHP2 inhibitor.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation under the Generating Antibiotic Incentives Now (GAIN) Act for AR-301, a fully human IgG1 monoclonal antibody (mAb) currently in Phase 3 clinical development as an adjunctive therapy for pneumonia caused by gram-positive Staphylococcus aureus in critically ill hospitalized patients.

Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced that it has named Mridul Malhotra to the dual role of Chief Strategic Officer and Global Head: Evidence, Value, and Access.

Apollo Medical Holdings, Inc. announced that it and its affiliated professional entity have entered into a definitive agreement to acquire assets relating to Texas Independent Providers, LLC.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, announced a favorable coverage policy from Highmark Inc.